Insulin Delivery Devices Market is Expected to Reach $19.8 Billion by 2025| Top Industry Players Eli Lilly and Company; Medtronic

San Francisco, 2 November 2018: The insulindelivery devices market is expected to reach USD 19.8 billion by 2025, according to a new report by Grand View Research, Inc. The global industry is estimated to witness a high growth during the forecast period from 2016 to 2025. Rapidly increasing number of diabetics coupled with the escalating attention around diabetes care is a major factor propelling the market.

Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices. 

Technological innovations and advancements are an ongoing trend in this vertical. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices is a major factor restraining the growth of this industry.

Access Research Report of Insulin Delivery Devices Market @ www.grandviewresearch.com/industry-analysis/insulin-delivery-devices-market

Further Key Findings from the Study Suggest:

·       The insulin pens segment was the largest revenue-generating category of this market in 2015. The pen is equipped with self-contained cartridges and offers ease in handling & less pain while injecting insulin. Advantages of these pen devices over other products are resulting in its growing popularity, thus serving as a vital factor in contributing to the sector’s highest share in this market.

·       Homecare is estimated to be the largest shareholder and the fastest growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients.

·       North America is the leading regional sector and accounted for the largest revenue share in 2015 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting the market growth. 

·       The Asia Pacific region is anticipated to be the fastest growing market during the forecast period. The high prevalence rate of diabetes in the Asian countries, such as China and India, is a major factor contributing to market expansion in this region.

·       Some key players serving this vertical include Novo Nordisk A/S; Sanofi; Eli Lilly and Company; Medtronic; Becton, Dickinson and Company; Abbott; and F. Hoffmann-La Roche Ltd. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the insulin delivery devices market on the basis of product, end-use, and region:

Insulin Delivery Devices Market Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Insulin syringes

·         Insulin pens

·         Insulin pumps

·         Insulin injectors

Insulin Delivery Devices End-use Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals

·         Home care

·         Others            

Insulin Delivery Devices Market Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·          Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa

Access Press Release of Insulin Delivery Devices Market@ www.grandviewresearch.com/press-release/global-insulin-delivery-devices-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Monoclonal Antibodies (mAbs) Market Set to Record Exponential Growth by 2024|Key Industry Participants Novartis AG, Merck & Co., Inc

San Francisco, 2 November 2018: The global monoclonalantibodies (mAbs) market was valued at USD 85.4 billion in 2015 and is expected to reach a value of USD 138.6 billion by 2024. Increasing R&D pertaining to the development of therapeutic mAbs coupled with supportive government initiatives is expected to drive the monoclonal antibodies market growth over the forecast period.

Increasing demand for personalized medicine is a vital factor responsible for the increasing development of therapeutic antibodies to provide targeted therapies as every individual responds in a different manner to a particular treatment. Moreover, related benefits of using mAbs for therapeutic purposes, including fewer adverse effects, homogeneity, specificity, and large-scale production, are contributing toward significant market growth.

In addition, the government initiatives to enable cost-effective production of mAbs is anticipated to propel the emergence of this sector over the forecast period. For instance, the biomanufacturing initiative byNational Institute of Standards and Technology in the U.S. provides scientifically sound regulatory guidelines to ensure effective and safe manufacturing of protein therapeutics and to support biopharmaceutical manufacturers in offering low-cost and high-quality protein drugs across the globe.

Access Research Report of Monoclonal Antibodies (mAbs) Market @ www.grandviewresearch.com/industry-analysis/monoclonal-antibodies-market

Further Key Findings from the Study Suggest:

·       Human-based mAbs segment is predicted to grow at a lucrative CAGR in the coming years due to their associated benefits and numerous R&D activities conducted for further development of human mAbs. Large number of mAbs of human origin are in phase III clinical trial for cancer treatment

·       In vitro production of mAbs is anticipated to show the fastest growth owing to its wide-scale adoption by biologics manufacturers due to its greater efficiency in cost and time

·       The research institute segment is anticipated to exhibit profitable growth due to increasing R&D efforts in the biotech industry as monoclonal antibodies have emerged as a major class of therapeutics for several human diseases, particularly immunological infectious diseases and cancer

·       The Asia pacific region has significant growth potential due to rising government initiatives in this region supporting the use of mAbs for research and treatment purposes coupled with the surge in sponsored R&D projects for the development of cost-effective therapeutic mAbs.

·       For instance, government-led fund providers, such as National Natural Science Foundation and National Basic Research Program of China, offer financial support to enterprises and universities to conduct mAb research and development.

·       The key players serving the monoclonal antibodies market arePfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc, Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., Daiichi Sankyo Company, Ltd., Bayer AG, Bristol Myers Squibb Co.,Johnson & Johnson Services, Inc., Biogen Inc., Thermo Fisher Scientific, Inc., Sanofi Genzyme, F. Hoffmann-La Roche Ltd., and Novo Nordisk A/S.

·       The introduction of advanced methods for mAb production further encourages the pharmaceutical companies to build their own product pipeline. According to a study published by NCBI at the end of 2013, approximately 816 companies were involved in therapeutic protein research. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the monoclonal antibodies market by source type, production, indication, end-use, and region:

Global Monoclonal Antibodies Source Type Outlook (Revenue, USD Billion, 2013 - 2024)

·         Murine

·         Chimeric

·         Humanized

·         Human 

Global Monoclonal Antibodies Production Type Outlook (Revenue, USD Billion, 2013 - 2024)

·         In Vivo

·         In Vitro

Global Monoclonal Antibodies Indication Outlook (Revenue, USD Billion, 2013 - 2024)

·         Cancer

·         Autoimmune Diseases

·         Inflammatory Diseases

·         Infectious Diseases

·         Microbial Diseases

·         Others

Global Monoclonal Antibodies End-use Outlook (Revenue, USD Billion, 2013 - 2024)

·         Hospitals

·         Research Institutes

·         Others

Monoclonal antibodies Market Regional Outlook (Market Revenue in USD Billion, 2013 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa

Access Press Release of Monoclonal Antibodies (mAbs) Market@ www.grandviewresearch.com/press-release/global-monoclonal-antibodies-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Marketing Automation Software Market is Expected to Reach $7.63 Billion by 2025| Key participants HubSpot, Inc., IBM Corporation

San Francisco, 2 November 2018: According to a report published by Grand View Research, Inc.; marketingautomation software market is expected to reach a valuation of around USD 7.63 billion by 2025.

Increasing demand for the software for customer lifecycle marketing, lead generation management, and customer retention can propel the market over the forecast period (2014 to 2025).

The software help organizations to automate repetitive tasks such as emails, social media, and several other website functions to save time, efforts, and costs. Increasing acceptance of SaaS model and growing dependency on social media for information is expected to promote the demand for this software. Consumers across the world have transformed traditions of perceiving information and exploring products and services before purchase. Consumers have become tech-savvy and highly dependent on information available on social media sites, blogs, search engines. This has encouraged companies to develop strong consumer relationship interface that can offer better experience. The solutions are extensively implemented across the business to business (B2B) as well as business to consumer (B2C) business models. The B2B industries such as software, manufacturing and business services were the early adopters of the technology. But, the technology is increasingly implemented in B2C industries including media and entertainment, financial services, retail, and healthcare.

Worldwide marketing automation market can be segmented on the basis of solution, enterprise size, deployment, application, and region.

Access Research Report of Marketing Automation Software Market@ www.grandviewresearch.com/industry-analysis/marketing-automation-software-market

Based on solution, the market can be segmented on the basis of campaign management, inbound marketing, email marketing, lead management, mobile applications, social media marketing, reporting and analytics, and others.

In 2015, the email marketing segment estimated for 30% of the overall market share. But, the reporting and analytics segment is anticipated to grow at the highest CAGR of 13.3% during the forecast period. This technology is expected to be useful in manufacturing and expected to expand at an estimated CAGR of 11.88% during 2016 to 2025.

As per enterprise size, the market can be classified into small and mid-sized enterprises (SME) and large enterprise. Earlier the use of technology was limited to large enterprisers. However, the SME segment is expected to be the largest segment due to increasing adoption of the technology

On the basis of deployment, the market can be bifurcated into cloud and on-premises.

The cloud segment is expected to dominate during the forecast period due to its cost effectiveness as it eliminates the hardware installations. This deployment type also helps to improve customer interaction by providing accessibility of single source of information to organization.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Based on application, the market can be split into BFSI, government and education, retail, telecom and IT, healthcare, discrete manufacturing, and others.

In 2015, the telecom and IT segment together estimated over 23% of overall market revenue. Though, the discrete manufacturing segment is projected to expand at the highest CAGR during the forecast period.

Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

In 2015, North America estimated for the major revenue share of around 54% of the overall market. This growth can be credited to existence of numerous leading companies in the U.S.

Asia Pacific is projected to expand at a CAGR of 13.5% during 2016 to 2025.  Strong economic growth in developing countries such as India and China, which hold a huge customer base is expected to support the market growth in this region.  In addition, presence of diversity in culture, politics, and economic is also expected to boost the product demand as these factors are more critical to understand customer behavior. Due to these factors companies in this region are struggling to increase their customer retention and loyalty levels. This is also expected to increase the product demand to avoid additional expenses.

Some of the leading companies operating in the market include Act-On Software, Inc.; IBM Corporation; Adobe systems, Inc.; Salesforce.com, Inc., and HubSpot, Inc.

The market is extremely competitive and concentrated. Market participants are increasingly focusing on expansion of their product and service portfolios.

Access Press Release of Marketing Automation Software Market@ www.grandviewresearch.com/press-release/global-marketing-automation-software-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Mixed Mode Chromatography Resin Market to Witness a Pronounce Growth by 2025|Key Industry Participants Danaher Corp, W.R Grace

San Francisco, 2 November 2018: The global mixedmode chromatography resin market size is expected to reach USD 130.3 million by 2025, according to a new report by Grand View Research, Inc., exhibiting a 7.1% CAGR during the forecast period. Growing number of contract manufacturing organizations (CMOs) and contract research organizations (CROs), along with increasing use of chromatography resin in separation of monoclonal antibodies, is anticipated to propel the market.

The Ion exchange - Hydrophobic resin segment is expected to dominate the global market till 2025. Demand for this technique is attributed to growth in drug discovery by pharmaceutical companies. These companies use chromatography techniques to separate complex mixtures and purification of materials. Increasing number of epidemic diseases such as Zika and Ebola is expected to further boost the mixed mode chromatography resin market.

Asia Pacific, especially China and India, is expected to generate significant demand for mixed mode chromatography resin owing to growing pharmaceutical sector, coupled with abundance of high skilled workforce and increase in disposable income.

Presence of global pharmaceutical and biotechnology companies, along with their research and development facilities, has enabled North America to be a key market for mixed mode chromatography resin. Massive healthcare expenditure is also driving the expansion of the market in this region.

Access Research Report of Mixed Mode Chromatography Resin Market @ www.grandviewresearch.com/industry-analysis/mixed-mode-chromatography-resin-market

Further key findings from the report suggest

·       The market is projected to exhibit a CAGR of 7.1% from 2018 to 2025 on account of budding pharmaceutical and biotechnology sector

·       Ion exchange - Hydrophobic Resin will witness the fastest growth in terms of revenue at a CAGR of 7.6% from 2018 to 2025

·        Asia Pacific is expected to grow at a significant pace and was valued at USD 22.4 million in 2017 on account of increasing number of pharmaceutical companies and rising expenditure in healthcare

·       Key players in the market include Merck KGaA, Purolite Corp, Danaher Corp, W.R Grace, GE Healthcare Lifesciences, and Bio-Rad Labs

·       In November 2015, Sigma-Aldrich was acquired by Merck KGaA, allowing the company to foray into the chromatography market.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/organic-chemicals-and-compounds

Grand View Research has segmented the global mixed mode chromatography resin market on the basis of technique, end use, and region:

Mixed Mode Chromatography Resin Technique Outlook (Volume, Thousand Liters; Revenue, USD Million, 2014 - 2025)

·         Ion exchange - Hydrophobic

·         Hydroxyapatite

·         Others

Mixed Mode Chromatography Resin End-use Outlook (Volume, Thousand Liters; Revenue, USD Million, 2014 - 2025)

·         Pharmaceutical & Biotechnology

Mixed Mode Chromatography Resin Regional Outlook (Volume, Thousand Liters; Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

·         Europe

o    U.K.

o    Germany

o    France

·         Asia Pacific

o    China

o    India

o    Japan

o    South Korea

Access Press Release of Mixed Mode Chromatography Resin Market@ www.grandviewresearch.com/press-release/global-mixed-mode-chromatography-resin-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Lithium-Ion Battery Market is Expected to Reach $93.1 Billion by 2025| Top Industry Players GS Yuasa International Ltd., Samsung SDI Co., Ltd

San Francisco, 2 November 2018: According to a report by Grand View Research, Inc.; the global lithium-ionbattery market is anticipated to attain USD 93.1 billion by 2025. Growing requirement for cost-effective and light-weight energy storage solutions is anticipated to propel market growth over the forecast period (2018 to 2025). This battery can offer high safety level and energy density as compared to conventional batteries. This factor is anticipated to fuel demand in near future.

Increasing number of photovoltaic (PV) installations and nuclear power plants attributed to commencement of new wind energy projects can positively influence market growth. Rising adoption of lithium-ion batteries in medical equipment can stimulate market over the next few years. Rising use in portable electronics, electric vehicles, and grid storage systems attributed to high safety level and energy density can spur market growth during the forecast period.

The worldwide lithium-ion battery market can be segregated on the basis of product, application, and region. Based on product, the market can be categorized into Lithium Cobalt Oxide (LCO), Lithium Iron Phosphate (LFP), lithium Nickel Cobalt Aluminum oxide (NCA), Lithium Manganese Oxide (LMO), Lithium Titanate (LTO), and Lithium Nickel Manganese Cobalt (NMC). In 2016, NMC dominated the market and accounted for around 26% of market share. Growing adoption in e-bikes, powder tools, and other electronic powertrains on account of its higher energy density, longer lifecycle, and lower cost can fuel demand over the forecast period. In addition, NMC can offer high capacity, high power, high performance, and excels on specific energy.

Access Research Report of Lithium-Ion Battery Market@ www.grandviewresearch.com/industry-analysis/lithium-ion-battery-market

Similarly, the LFP segment is likely to expand at a CAGR of 17.5% from 2017 to 2025. LFP batteries can offer advanced safety and long life span to product. There is a high demand from stationary and portable applications due to requirement for high load currents and endurance. This, in turn, can positively influence market growth over the forecast period. In addition, continual R&D activities by manufacturing companies for development of high-quality and effective products can augment market expansion. Moreover, favorable government regulations coupled with provision of subsidiaries for Electric Vehicles (EVs) can fuel product sales.

Based on application, the market can be classified into automotive, energy storage systems, consumer electronics, and industrial. In 2016 consumer electronics dominated the market and accounted for largest market share equivalent to USD 11.92 billion. Reliability and high durability of these batteries in consumer appliances such as smartphones and laptops can influence market growth over next few years. In addition, expanding electronics sector in countries like Japan, Taiwan, China, and South Korea can fuel demand for lithium-ion batteries during the forecast period.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/power-generation-and-storage

Similarly, energy storage systems segment is expected to expand at CAGR of 21% from 2017 to 2025 attributed to increasing off-grid installations. Favorable government initiatives coupled with growing number of solar PV installations in China, United States, and Germany can augment market growth. Moreover, rising concern for air pollution, carbon emissions, and greenhouse gases can fuel adoption of solar power during the forecast period.

Regional segmentation includes Europe, North America, Asia Pacific, Central and South America, and Middle East and Africa. Asia Pacific is expected to expand at CAGR of 17.7% from 2017 to 2025. Growing demand for tablets and mobiles in China, Japan, India, and Thailand among other countries can propel regional market. Rising lithium-ion battery production capacity in China by numerous market players including Panasonic, LG, and Contemporary Amperex Technology Ltd. (CATL) can further fuel expansion. Moreover, rising government subsidies for electric vehicles is likely to create immense market potential over the forecast period. Wind capacity output can cross 200GW by 2020 and can drive demand for energy storage systems in the country. This, in turn, can influence market growth over next few years.

In North America, the market is anticipated to witness substantial growth during the forecast period. This expansion can be attributed to increasing sale of consumer electronics and electric vehicles sales in countries including Mexico and United States. Rising demand for lithium-ion batteries in smartphones owing to their ability ty offer extended shelf life and enhanced efficiency can augment demand in the forthcoming years.

Some of the leading companies operating in the global lithium-ion battery market are BYD Co., Ltd, LG Chem, Panasonic, Samsung, and GS Yuasa Corporation.

Access Press Release of Lithium-Ion Battery Market@ www.grandviewresearch.com/press-release/global-lithium-ion-battery-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com